StockNews.com assumed coverage on shares of Bellerophon Therapeutics (NASDAQ:BLPH – Free Report) in a report released on Wednesday morning. The brokerage issued a hold rating on the biotechnology company’s stock.
Bellerophon Therapeutics Stock Performance
Shares of NASDAQ BLPH opened at $0.04 on Wednesday. Bellerophon Therapeutics has a twelve month low of $0.03 and a twelve month high of $0.10. The stock has a fifty day simple moving average of $0.04 and a 200-day simple moving average of $0.05. The stock has a market capitalization of $440,388.00, a PE ratio of -0.04 and a beta of 0.70.
About Bellerophon Therapeutics
Recommended Stories
- Five stocks we like better than Bellerophon Therapeutics
- The Risks of Owning Bonds
- Chinese Stocks Cool Off: Time to Buy the Dip in These 2 Stocks?
- Why Invest in High-Yield Dividend Stocks?
- Goldman Sachs Highlights 3 Top Short Squeeze Stocks to Watch
- P/E Ratio Calculation: How to Assess Stocks
- Walmart is Up 56% YTD, Is it Still a Top Consumer Staples Stock?
Receive News & Ratings for Bellerophon Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bellerophon Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
